A formulation strategy for gamma secretase inhibitor ELND006, a BCS class II compound: development of a nanosuspension formulation with improved oral bioavailability and reduced food effects in dogs.
暂无分享,去创建一个
E. Merisko-Liversidge | G. Liversidge | G. Tonn | J. Sauer | W. Hoffman | K. Quinn | R. Gullapalli | E. Goldbach | Angelina Wong | J. Bullock